For anyone who’s in the president’s crosshairs—or who could be—it’s the dominant emotion of Trump’s second term.

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine evaluation. A 2023–24 vaccine effectiveness analysis of immunocompetent adults ...